Literature DB >> 8298129

Isolation and characterization of a TATA-less promoter for the human beta 3 integrin gene.

M Villa-Garcia1, L Li, G Riely, P F Bray.   

Abstract

Proper expression of the human platelet fibrinogen receptor is necessary for the maintenance of normal hemostasis. This receptor is formed by the heterodimer alpha IIb beta 3, a prototypic member of the integrin family of adhesive molecules. beta 3 is also expressed in other tissues with alpha v as the vitronectin receptor. It was not possible to study the basis for tissue-specific expression of this gene, because the beta 3 gene promoter had not been isolated previously. We have now isolated a 6.0-kb human genomic DNA fragment containing 2.0 kb of sequence 5' to the beta 3 ATG start codon. This clone also contains sequence encoding the signal peptide of the immature beta 3 protein and 3.0 kb of 3' intronic sequence. Primer extension and RNase protection studies of poly A+ RNA from a human erythroleukemia (HEL) cell line indicated a major transcription start site 30 bp upstream of the ATG start codon. In an orientation-dependent manner, a 584-bp fragment 5' to the start codon promotes expression of the chloramphenicol acetyl transferase (CAT) reporter gene in K562 cells. CAT expression from this beta 3 promoter is fivefold above expression from a "promoter-less" control CAT construct. This beta 3 promoter lacks TATA and CAAT cis-acting elements, but there are two Sp1 sites flanking the transcription start site. Other potential transcription factor binding sites are also identified. Phorbol esters (TPA), which increase beta 3 transcription in K562 cells, stimulated transcription from the 584-bp 5' beta 3 region. The isolation of this beta 3 promoter region should permit a more detailed analysis of its transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8298129

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Role of the AP-1 transcription factor FOSL1 in endothelial cells adhesion and migration.

Authors:  Federico Galvagni; Maurizio Orlandini; Salvatore Oliviero
Journal:  Cell Adh Migr       Date:  2013-07-25       Impact factor: 3.405

2.  NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.

Authors:  Erik Hedrick; Syng-Ook Lee; Ravi Doddapaneni; Mandip Singh; Stephen Safe
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

3.  Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.

Authors:  Y Jin; H C Dietz; R A Montgomery; W R Bell; I McIntosh; B Coller; P F Bray
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

4.  Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.

Authors:  S A Johnson; N Mandavia; H D Wang; D L Johnson
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

5.  Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.

Authors:  D Woods; H Cherwinski; E Venetsanakos; A Bhat; S Gysin; M Humbert; P F Bray; V L Saylor; M McMahon
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB.

Authors:  Diane Crighton; Annette Woiwode; Cheng Zhang; Nihar Mandavia; Jennifer P Morton; Lorna J Warnock; Jo Milner; Robert J White; Deborah L Johnson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

7.  NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

Authors:  Tania N Crotti; Merrilee Flannery; Nicole C Walsh; Joseph D Fleming; Steven R Goldring; Kevin P McHugh
Journal:  Gene       Date:  2006-03-02       Impact factor: 3.688

8.  Regulation of cell proliferation and migration by TAK1 via transcriptional control of von Hippel-Lindau tumor suppressor.

Authors:  Siew Hwey Tan; Mintu Pal; Ming Jie Tan; Marc Hai Liang Wong; Fong U Tam; Jamie Wei Ting Teo; Han Chung Chong; Chek Kun Tan; Yan Yih Goh; Mark Boon Yang Tang; Peter Ching For Cheung; Nguan Soon Tan
Journal:  J Biol Chem       Date:  2009-05-06       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.